MedTrace Logo

External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy

NCT01978470 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-04-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the tolerability and safety of the NeuroSigma eTNS system.

Conditions

  • Seizure Disorder

Interventions

DEVICE

External Trigeminal Nerve Stimulation (eTNS)

External stimulation of the trigeminal nerve.

Sponsors & Collaborators

  • Olive View-UCLA Education & Research Institute

    collaborator OTHER

  • NeuroSigma, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-06-30
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01978470 on ClinicalTrials.gov